Log In
Print this Print this

biosimilar trastuzumab (SB3)

  Manage Alerts
Collapse Summary General Information
Company Samsung Group
DescriptionBiosimilar of trastuzumab, a humanized mAb against epidermal growth factor receptor 2 (EGFR2; HER2; ErbB2; neu)
Molecular Target Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu)
Mechanism of ActionBinds HER2/neu; Antibody; Biosimilar
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentRegistration
Standard IndicationBreast cancer
Indication DetailsTreat HER2 positive breast cancer
Regulatory Designation
PartnerBiogen Inc.;
Merck & Co. Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today